30
/es/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
3512552
319423
2
Public Timelines FAQ
Public TimelinesFAQ
Public TimelinesFAQ
For educational institutions For teachers For students Open cabinet
For educational institutions For teachers For students Open cabinet
Crear
Create a timeline
Public timelines
Library
FAQ

1 ene 1998 año - Trastuzumab

Descripción:

For the treatment of women with HER2-positive metastatic breast cancer, the Food and Drug Administration (FDA) recommends trastuzumab, a monoclonal antibody that inhibits cancer cells that overproduce the HER2 protein.

Añadido al timeline:

Cancer

ByTrinity Ozias
14 nov 2019

fecha:

1 ene 1998 año
Ahora mismo
~ 26 years ago
About & FeedbackAcuerdoPrivacidadBiblioteca
2024 © Time.Graphics
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews
Write your own review on Trustpilot.com